mRNA SARS-CoV-2 vaccination during pregnancy confers greatest protection for newborns
1. In a retrospective cohort of Singaporean, maternal mRNA SARS-CoV-2 vaccination during pregnancy was associated with a 41.5% reduction in SaR-CoV-2 infection for infants aged 6 months or less. 2. Vaccination during pregnancy demonstrated a larger risk reduction for infants than vaccinations administered prior to pregnancy. Evidence Rating Level: 2 (Good) Analysis of population data